Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Expected Years of Life Lost Due to Adult Cancer Mortality in Yazd (2004-2010)

  • Mirzaei, Mohsen (Department of Community Medicine, Health Monitoring Research Center, Shahid Sadoughi University of Medical Sciences) ;
  • Mirzadeh, Mahboobahsadat (Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences) ;
  • Mirzaei, Mojtaba (Tehran University of Medical Sciences & Health Services)
  • Published : 2016.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

The number of deaths is often measured to monitor the population health status and priority of health problems. However, number of years of life lost (YLL) is a more appropriate indicator in some cases. We have calculated the YLL of adult cancers and its trend over the past few years in Yazd to provide planners with baseline data. Data obtained from death registration system were used to calculate the YLL, based on each individual's age at death, and the standardized expected YLL method was applied with a discount rate of 0.03, an age weight of 0.04, and a correction factor of 0.165. All data were analyzed and prepared in Epi6 and Excel 2007. A total of 3,850 death records were analyzed. Some 550 patients in Yazd province aged ${\geq}20$ die annually due to cancer (male: female ratio 1.3). The average ages at death in lung, CNS, breast cancer and leukemia cases were 68.5, 59, 58.7 and 61, respectively. The age group of 40-59 with 21 % had the highest cancer mortality percentage. Premature cancer deaths have caused 40,753 YLL (5,823 YLL annually). Females lose on average more life years to cancer than do men (11.6 vs 9.8 years). Lung cancer (12.1%), CNS tumors (11.7%) and leukemia (11.4 %) were the leading causes terms of YLL due to all cancers in both sexes. From 2004 to 2010, cancer-caused YLL as a fraction of all YLL increased from 12.8 to 15.2 %. This study can help in the assessment of health care needs and prioritization. Cancer is the major cause of deaths and the trend is increasing. The use of YLLs is a better index for measurement of premature mortality for ranking of diseases than is death counts. Longer periods of observation will make these trends more robust and will help to evaluate and develop, better public health interventions.

Keywords

References

  1. Anand P, Kunnumakara AB, Sundaram C, et al (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharm Res, 25, 2097-116. https://doi.org/10.1007/s11095-008-9661-9
  2. Aragon TJ, Lichtensztajn DY, Katcher BS, et al (2008). Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health, 8, 116. https://doi.org/10.1186/1471-2458-8-116
  3. Baeradeh NA, Lotfi MH, Fallahzadeh H, et al (2015). Survival rate of patients with stomach cancer and its effective factors in Yazd province. Journal of Community health Research, 3, 278-87.
  4. Brustugun OT, Moller B, Helland A (2014). Years of life lost as a measure of cancer burden on a national level. Br J Cancer, 111, 1014-20. https://doi.org/10.1038/bjc.2014.364
  5. Burnet NG, Jefferies SJ, Benson RJ, et al (2005). Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. Br J Cancer, 92, 241-5. https://doi.org/10.1038/sj.bjc.6602321
  6. Carter AJ, Nguyen CN (2012). A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC public health, 12, 526. https://doi.org/10.1186/1471-2458-12-526
  7. Chu DM, Wahlqvist ML, Lee MS, et al (2011). Central obesity predicts non-Hodgkin's lymphoma mortality and overall obesity predicts leukemia mortality in adult Taiwanese. J Am Coll Nutr, 30, 310-9. https://doi.org/10.1080/07315724.2011.10719974
  8. Etemadi A, Sadjadi A, Semnani S, et al (2008). Cancer registry in Iran: a brief overview. Arch Iran Med, 11, 577-80.
  9. Fallahzadeh H, Momayyezi M, Akhundzardeini R, et al (2014). Five year survival of women with breast cancer in Yazd. Asian Pac J Cancer Prev, 15, 6597-601. https://doi.org/10.7314/APJCP.2014.15.16.6597
  10. Fateh M, Emamian MH (2013). Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 - 2010. Iran J Cancer Prev, 6, 85-94.
  11. Fazeli Z, Pourhoseingholi MA, Vahedi M, et al (2013). Leukemia cancer mortality trend in Iran, From 1995 to 2004. Iran J Cancer Prev, 6, 170-3.
  12. Fitzmaurice C, Dicker D, Pain A, et al (2015). The Global burden of cancer 2013. JAMA Oncol, 1, 505-27. https://doi.org/10.1001/jamaoncol.2015.0735
  13. Gardner JW, Sanborn JS (1990). Years of potential life lost (YPLL)-what does it measure?. Epidemiology, 1, 322-9. https://doi.org/10.1097/00001648-199007000-00012
  14. Hadad K, Mokhtari J (2015). Indoor radon variations in central Iran and its geostatistical map. Atmos. Environ, 102, 220-7. https://doi.org/10.1016/j.atmosenv.2014.12.013
  15. Harirchi I, Ghaemmaghami F, Karbakhsh M, et al (2005). Patient delay in women presenting with advanced breast cancer: an Iranian study. Public Health, 119, 885-91. https://doi.org/10.1016/j.puhe.2004.11.005
  16. Hassan LM, Mahmoud N, Miller AB, et al (2015). Evaluation of effect of self-examination and physical examination on breast cancer. Breast J, 24, 491-6. https://doi.org/10.1016/j.breast.2015.04.012
  17. Imamura Y, Mizuno S (2005). Comparison of leukemia mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol, 35, 420-3. https://doi.org/10.1093/jjco/hyi116
  18. Keyghobadi N, Rafiemanesh H,Mohammadian-Hafshejani A, et al (2015). Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev, 16, 1409-13. https://doi.org/10.7314/APJCP.2015.16.4.1409
  19. Khajedaluee M, Dadgarmoghaddam M, Saeedi R, et al (2014). Mortality, morbidity, survival, and burden of top 9 cancers in a developing country. Razavi Int J Med, 2, 20073.
  20. Khan A (2000). A study of indoor radon levels in Indian dwellings, influencing factors and lung cancer risks. Radiat. Meas, 32, 87-92. https://doi.org/10.1016/S1350-4487(99)00275-9
  21. Khorasani S, Rezaei S, Rashidian H, et al (2015). Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran. Asian Pac J Cancer Prev, 16, 1845-50. https://doi.org/10.7314/APJCP.2015.16.5.1845
  22. Kushi LH, Doyle C, McCullough M, et al (2012). American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin, 62, 30-67. https://doi.org/10.3322/caac.20140
  23. Lee WC (1997). Quantifying the future impact of disease on society: life table-based measures of potential life lost. Am. J Public Health, 87, 1456-60. https://doi.org/10.2105/AJPH.87.9.1456
  24. Liu PH, Wang JD, Keating NL (2013). Expected years of life lost for six potentially preventable cancers in the United States. Prev Med, 56, 309-13. https://doi.org/10.1016/j.ypmed.2013.02.003
  25. Lotfi M, Shobairi SCS (2008). Breast cancer risk factors in an urban area of Yazd City-Iran, 2006. Acta Med Iranica, 46, 253-7.
  26. Lozano R, Naghavi M, Foreman K, et al (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-128. https://doi.org/10.1016/S0140-6736(12)61728-0
  27. Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
  28. Miller AB, Harirchi I, Lotfi MH, et al (2015). Yazd breast cancer project profile; a community based trial for the evaluation of self-examination and physical examination of the breast cancer disease. Iran J Basic Med Sci, 40, 531-6.
  29. Mirzadeh M, Mirzaei M, Mirzaei M, et al (2015). Years of Life Lost and Childhood and Adolescent Cancer Mortality in Yazd Province, Iran (2004-2009). Iran J Ped Hematol Oncol, 5, 125-30.
  30. Mojibyan M, Karimi M, Bidaki R, et al (2013). Exposure to second-hand smoke during pregnancy and preterm delivery. Int J High Risk Behav, 1, 149-53.
  31. Naghavi M, Abolhassani F, Pourmalek F, et al (2009). The burden of disease and injury in Iran 2003. Popul Health Metr, 7, 9. https://doi.org/10.1186/1478-7954-7-9
  32. Namayandeh S, Sadr S, Ansari Z, et al (2011). A cross-sectional study of the prevalence of coronary artery disease traditional risk factors in Yazd urban population, Yazd healthy heart project. Int J Cardiovasc Res, 5, 7-13.
  33. Pirsaheb M, Najafi F, Khosravi T, et al (2013). A systematic review of radon investigations related to public exposure in Iran. Iran. Red. Crescent, 15, 10204.
  34. Rouse C, Gittleman H, Ostrom QT, et al (2015). Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. Neuro Oncol, 4, 608-619.
  35. Thun MJ, DeLancey JO, Center MM, et al (2010). The global burden of cancer: priorities for prevention. J Carcinog, 31, 100-10. https://doi.org/10.1093/carcin/bgp263
  36. Vakili M, Pirdehghan A, Adimi M, et al (2014). Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009. J Res Health Sci, 14, 210-3.
  37. Varadarajan R, Cummings MK, Hyland AJ, et al (2010). Can decreasing smoking prevalence reduce leukemia mortality?. Ann Hematol, 89, 873-6. https://doi.org/10.1007/s00277-010-0957-6
  38. Yalla M, Abedini M, Hassanzadeh R (2013). Life expectancy in brain tumor patients and healthy subjects. Intl Res J Appl Basic Sci, 5, 251-4.
  39. Zahedi A, Rafiemanesh H, Enayatrad M, et al (2015). Incidence, trends and epidemiology of cancers in North West of Iran. Asian Pac J Cancer Prev, 16, 7189-93. https://doi.org/10.7314/APJCP.2015.16.16.7189
  40. Zeinalzadeh AH, Kousha A, Abdullahi L, et al (2012). Pattern of age distribution of different cancers in East Azerbaijan province, Iran. J Kerman Univ Med Sci, 19, 308-86.

Cited by

  1. The Association of Dietary Quality Indices and Cancer Mortality: A Systematic Review and Meta-analysis of Cohort Studies pp.1532-7914, 2018, https://doi.org/10.1080/01635581.2018.1502331